key: cord-0707314-1bjdtndf
authors: Stensland, Kristian D.; Morgan, Todd M.; Moinzadeh, Alireza; Lee, Cheryl T.; Briganti, Alberto; Catto, James W.F.; Canes, David
title: Considerations in the Triage of Urologic Surgeries During the COVID-19 Pandemic
date: 2020-04-09
journal: Eur Urol
DOI: 10.1016/j.eururo.2020.03.027
sha: 2b5956840121bf9c1e047ed0f3ef2fbae6cf846b
doc_id: 707314
cord_uid: 1bjdtndf

We present a suggested list of urologic surgeries that should be prioritized if COVID-19 surges warrant cancellation of elective surgeries to free up health care resources. The recommendations should be tailored to locally available resources and situations and can be used as a framework for other specialties.

Will the global pandemic change short-term progression and/or mortality rates for aggressive urologic cancers? And will this affect the in-hospital mortality and complication rates for frail patients with aggressive genitourinary malignancies? Prior data on delays to care are the best current guide by which we can begin to select cases to prioritize in the face of acutely decreased resources and diversion of operative resources to care for COVID-19 patients.

We have put together preliminary recommendations in that regard and discuss the rationale for these difficult decisions. These suggestions were curated with input from multiple departments in the USA and Europe. In general, considerations should include nonsurgical treatments when available or deferral of surgery until the demand for ventilators and inpatient beds falls, where possible. Table 1 is a suggested list of surgeries that should be prioritized if COVID-19 surges warrant cancellation of most elective surgery. These recommendations, which can be applied in the current and any future situation in which ventilators and other operating room resources are scarce, prioritize moving forward with cases where evidence suggests that even short-term delays may affect patient survival. We also suggest alternatives for the management of common urgent or emergent urologic procedures that may spare the use of ventilators, and consider the use and impact of common urologic treatments on patients during an infectious outbreak. Finally, while we do not incorporate patient age and frailty into these recommendations, the risk of a postoperative COVID-19 infection and its potential impact on a patient's postoperative course should also be considered.

a v a i l a b l e a t w w w . s c i e n c e d i r e c t . c o m j o u r n a l h o m e p a g e : w w w . e u r o p e a n u r o l o g y . c o m [3] , decreases OS and progression-free survival [4] , and is associated with higher pathologic stage [5] 5-8 d (USA) [6, 7] Cystectomy for CIS refractory to third-line therapy TURBT for suspected cT1+ bladder tumors cT1 tumors are understaged in up to 50% of cases, representing a significant risk of missed MIBC [8] Outpatient procedure Testicular cancer Orchiectomy for suspected testicular tumors Limited data on survival after delay to orchiectomy [9] , but orchiectomy is an outpatient procedure with potential OS benefit and should be prioritized [10] Orchiectomy: outpatient procedure

To spare a ventilator and inpatient stay (RPLND), radiation post-orchiectomy can be encouraged when surveillance is not an option. Chemotherapy use should be balanced by concern for immunosuppression and increased risk of COVID-19 infection/sequelae RPLND: 4-6 d (open) [11] Favor chemotherapy or radiation rather than RPLND when clinically appropriate 1-3 d (minimally invasive) [12] Kidney cancer Nephrectomy for cT3+ tumors, including all patients with renal vein and/or IVC thrombi More advanced renal tumors, particularly with associated vein thrombi, may progress rapidly and create more complicated surgeries and adversely affect survival and/or surgical morbidity [13] Nephrectomy: 3 d [14] Planned partial or radical nephrectomy for cT1 masses should be delayed or other forms of ablative approaches should be considered in selected patients IVC thrombectomy: 5-10 d [15] Planned partial or radical nephrectomy for cT2 should be considered for delay based on patient considerations, such as age, morbidity, symptoms, and tumor growth rate For cT1-2 (stage I-II) masses, delaying surgery by 3 mo has not been associated with decreased CSS or OS 1-2 d (minimally invasive)

Most prostatectomies should be delayed Surgery for NCCN high risk may be considered, depending on patient age and disease risk. However, given the availability of other treatment modalities, these surgeries may receive lower prioritization than others on this list (as delay of treatment up to 12 mo, even for high risk disease, may not alter operative outcomes, cancer specific mortality, or other outcomes).

Shared decision-making to consider radiation therapy for NCCN high-risk disease Biochemical recurrence rates may be higher in highrisk men who delay definitive treatment, but there is not a clear cut-off time for this treatment benefit [17] [18] [19] Surgery for NCCN high-risk disease if patient is ineligible for radiation Selected high-risk patients and those with intermediate-or low-risk cancer should be delayed UTUC Nephroureterectomy for high-grade and/or cT1+ tumors 3-mo delay to surgery for UTUC has been associated with disease progression for all patients, and with CSS for patients with muscle-invasive disease [9, 21] 1-4 d [23] Early-stage particularly invasive UTUC has a high risk of being understaged [22] Adrenal tumors Adrenalectomy for suspected ACC or tumors >6 cm Adrenal masses >6 cm are much more likely to harbor carcinoma 0-1 d [25] Consider delay of adrenalectomy for less suspicious adrenal masses (<6 cm, favorable imaging characteristics) ACC progresses rapidly, and achieving R0 at surgery provides the best chance of survival. Delay may decrease resectability and affect survival [24] Urethral/penile cancer Clinically invasive or obstructing cancers Data for these rare tumors are limited. Preventing lymph node metastases may spare significant patient morbidity. Furthermore, partial penectomy can be an outpatient procedure that puts a lower strain on hospital resources.

Endourology/stone disease Stones For obstruction/infection When possible, stents can be placed at the bedside to spare a ventilator [26] Outpatient procedure (unless concurrent infection) Ureteral stent insertion Nephrostomy tubes can be placed under local anesthesia, sparing a ventilator Consideration for awake, bedside ureteral stent placement under local anesthesia If neither option is possible, an obstructed or infected upper tract is an emergency requiring intervention Consideration for nephrostomy tube E U R O P E A N U R O L O G Y X X X ( 2 0 1 9 ) X X X -X X X E U R O P E A N U R O L O G Y X X X ( 2 0 1 9 ) X X X -X X X As with all guidelines, these recommendations must be tailored to locally available resources and situations. This document reflects preliminary expert opinion from this group, and by no means should these recommendations be considered rigid or all-encompassing. It is our hope that this preliminary evidence and opinion may provide a starting point for discussions at a local level. Furthermore, other surgical service lines can use these urology recommendations as a framework in creating their own specialty-specific recommendations.

Conflicts of interest: The authors have nothing to disclose.

COVID-19: recommendations for management of elective surgical procedures 2020

Stepping forward: urologists' efforts during the COVID-19 outbreak in Singapore

Determining the optimal time for radical cystectomy after neoadjuvant chemotherapy

Delaying radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer is associated with adverse survival outcomes

Urologic Diseases in America Project. Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis

Hospital charges and length of stay following radical cystectomy in the enhanced recovery after surgery era

Outcomes of an enhanced recovery after radical cystectomy program in a prospective multicenter study: compliance and key components for success

Timing and outcomes for radical cystectomy in nonmuscle invasive bladder cancer

Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival

Impact of diagnostic delay in testis cancer: results of a large population-based study

Effect of alvimopan on gastrointestinal recovery and length of hospital stay after retroperitoneal lymph node dissection for testicular cancer

The role of robotic retroperitoneal lymph node dissection for testis cancer

Growth of a level III vena cava tumor thrombus within 1 month

Predicting length of stay following radical nephrectomy using the National Surgical Quality Improvement Program database

Complex robotic nephrectomy and inferior vena cava tumor thrombectomy: an evolving landscape

Comparison of perioperative outcomes between robotic and laparoscopic partial nephrectomy: a systematic review and meta-analysis

Evaluating the effect of time from prostate cancer diagnosis to radical prostatectomy on cancer control: can surgery be postponed safely?

Interval from prostate biopsy to radical prostatectomy does not affect immediate operative outcomes for open or minimally invasive approach

Immediate versus delayed prostatectomy: Nationwide population-based study

Prolonged length of stay after robotic prostatectomy: causes and risk factors

A delay in radical nephroureterectomy can lead to upstaging

Ureteroscopy in the diagnosis of upper tract transitional cell cancer: a 10-year experience providing outcome data for informed consent

Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: results from three high-volume robotic surgery institutions

Adrenocortical carcinoma

Risk factors associated with perioperative complications and prolonged length of stay after laparoscopic adrenalectomy

Safety and efficacy of ureteral stent placement at the bedside using local anesthesia

Management of forgotten ureteral stents: relationship between indwelling time and required treatment approaches

Laser enucleation of the prostate versus transurethral resection of the prostate: perioperative outcomes from the ACS NSQIP database

press

length of stay, and mortality in kidney transplant recipients: a national registry and prospective cohort study

Acknowledgement: We thank Carol Spencer, the Lahey Clinic Librarian, for helping to rapidly gather relevant literature relating to delay of care for each urologic cancer type.